BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 31325847)

  • 21. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.
    Zong L; Zhang Q; Kong Y; Yang F; Zhou Y; Yu S; Wu M; Chen J; Zhang Y; Xiang Y
    Gynecol Oncol; 2020 Mar; 156(3):676-681. PubMed ID: 31882242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative outcomes of MR-invisible stage IB1 cervical cancer.
    Park JY; Lee JW; Park BK; Lee YY; Choi CH; Kim TJ; Bae DS; Kim BG; Park JJ; Park SY; Kim CK
    Am J Obstet Gynecol; 2014 Aug; 211(2):168.e1-7. PubMed ID: 24607752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications.
    Sandadi S; Tanner EJ; Khoury-Collado F; Kostolias A; Makker V; Chi DS; Sonoda Y; Alektiar KM; Barakat RR; Abu-Rustum NR
    Int J Gynecol Cancer; 2013 Mar; 23(3):553-8. PubMed ID: 23392402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.
    Yang E; Huang S; Ran X; Huang Y; Li Z
    BMC Cancer; 2021 Feb; 21(1):203. PubMed ID: 33639874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of laparoscopic versus abdominal radical hysterectomy for FIGO stage IB and IIA cervical cancer with tumor diameter of 3 cm or greater.
    Kong TW; Chang SJ; Lee J; Paek J; Ryu HS
    Int J Gynecol Cancer; 2014 Feb; 24(2):280-8. PubMed ID: 24407571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
    Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
    Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
    Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single-Institution Patient Cohort.
    Vengaloor Thomas T; Reddy KK; Gandhi S; Nittala MR; Abraham A; Robinson W; Ridgway M; Packianathan S; Vijayakumar S
    Cureus; 2021 Nov; 13(11):e19289. PubMed ID: 34877225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.
    Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
    Gynecol Oncol; 2001 May; 81(2):133-7. PubMed ID: 11330939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
    Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
    Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection.
    Hanprasertpong J; Jiamset I; Atjimakul T
    Tumour Biol; 2016 Jun; 37(6):7421-30. PubMed ID: 26678885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system.
    McComas KN; Torgeson AM; Ager BJ; Hellekson C; Burt LM; Maurer KA; Werner TL; Gaffney DK
    Gynecol Oncol; 2020 Jan; 156(1):85-92. PubMed ID: 31744640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
    Kosary CL
    Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.
    Garg G; Shah JP; Liu JR; Bryant CS; Kumar S; Munkarah A; Morris RT
    Int J Gynecol Cancer; 2010 Oct; 20(7):1201-6. PubMed ID: 20940535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?
    Finan MA; DeCesare S; Fiorica JV; Chambers R; Hoffman MS; Kline RC; Roberts WS; Cavanagh D
    Gynecol Oncol; 1996 Aug; 62(2):139-47. PubMed ID: 8751541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.